Net Margin: Boundless Bio, Inc. (BOLD)

Graphic logo of Boundless Bio Inc (BOLD)

Unique patents in oncotherapy create a powerful defensive moat, as evidenced by the net margin on this chart, where the value 0.00 determines this level. Boundless Bio, Inc. (BOLD) strengthens market confidence through its status as a pioneer in the fight against aggressive tumors. Meanwhile, strict FDA oversight and a preference for joint research over mergers limit the scaling pace of Boundless Bio, Inc. (BOLD).

BOLD: Boundless Bio Inc Net Profit Rate 03/29/2024 - 11/19/2026

Comprehensive metric breakdowns and analytics for Boundless Bio, Inc (BOLD)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Basic company analysis:Boundless Bio Inc., BOLD
Manufactured product of Boundless Bio Inc.

Net profit margin measures the efficiency of converting revenue into bottom-line profit after deducting all expenses. By analyzing the net profit margin, an investor assesses the business's ability to generate real cash flow. This ratio reveals the internal stability of the model and the level of operating leverage. For Boundless Bio, Inc. (BOLD), current negative values reflect a stage of intensive R&D expenditures. Future growth in this metric will signal the commercialization of therapies and the realization of a patent monopoly.

Competitors of Boundless Bio, Inc. (BOLD)

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin Sangamo SGMO|NAUT: Net Return on Sales|MGX: Return on Sales by Net Profit|Net Margin Precision BioSciences|GBIO (generationbio.com) - Return on Sales by Net Profit|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX